Anthropomorphic lung phantom based validation of in-room proton therapy 4D-CBCT image correction for dose calculation.
Animals
Chickens
Cone-Beam Computed Tomography
Four-Dimensional Computed Tomography
Humans
Image Processing, Computer-Assisted
Lung
Lung Neoplasms
/ diagnostic imaging
Male
Phantoms, Imaging
Proton Therapy
/ methods
Radiotherapy Dosage
Radiotherapy Planning, Computer-Assisted
/ methods
Spiral Cone-Beam Computed Tomography
Swine
4D-vCT
Cone-beam
Motion
Proton therapy
Thorax
Tomography
Journal
Zeitschrift fur medizinische Physik
ISSN: 1876-4436
Titre abrégé: Z Med Phys
Pays: Germany
ID NLM: 100886455
Informations de publication
Date de publication:
Feb 2022
Feb 2022
Historique:
received:
29
05
2020
revised:
18
09
2020
accepted:
23
09
2020
pubmed:
30
11
2020
medline:
9
3
2022
entrez:
29
11
2020
Statut:
ppublish
Résumé
Ventilation-induced tumour motion remains a challenge for the accuracy of proton therapy treatments in lung patients. We investigated the feasibility of using a 4D virtual CT (4D-vCT) approach based on deformable image registration (DIR) and motion-aware 4D CBCT reconstruction (MA-ROOSTER) to enable accurate daily proton dose calculation using a gantry-mounted CBCT scanner tailored to proton therapy. Ventilation correlated data of 10 breathing phases were acquired from a porcine ex-vivo functional lung phantom using CT and CBCT. 4D-vCTs were generated by (1) DIR of the mid-position 4D-CT to the mid-position 4D-CBCT (reconstructed with the MA-ROOSTER) using a diffeomorphic Morphons algorithm and (2) subsequent propagation of the obtained mid-position vCT to the individual 4D-CBCT phases. Proton therapy treatment planning was performed to evaluate dose calculation accuracy of the 4D-vCTs. A robust treatment plan delivering a nominal dose of 60Gy was generated on the average intensity image of the 4D-CT for an approximated internal target volume (ITV). Dose distributions were then recalculated on individual phases of the 4D-CT and the 4D-vCT based on the optimized plan. Dose accumulation was performed for 4D-vCT and 4D-CT using DIR of each phase to the mid position, which was chosen as reference. Dose based on the 4D-vCT was then evaluated against the dose calculated on 4D-CT both, phase-by-phase as well as accumulated, by comparing dose volume histogram (DVH) values (D Good agreement was found between the 4D-CT and 4D-vCT-based ITV-DVH curves. The relative differences ((CT-vCT)/CT) between accumulated values of ITV D Feasibility of the suggested 4D-vCT workflow using proton therapy specific imaging equipment was shown. Results indicate the potential of the method to be applied for daily 4D proton dose estimation.
Identifiants
pubmed: 33248812
pii: S0939-3889(20)30099-4
doi: 10.1016/j.zemedi.2020.09.004
pmc: PMC9948846
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
74-84Informations de copyright
Copyright © 2020. Published by Elsevier GmbH.
Références
Int J Radiat Oncol Biol Phys. 2012 Mar 1;82(3):e399-407
pubmed: 22284036
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):924-32
pubmed: 19801104
Radiat Oncol. 2018 Feb 5;13(1):19
pubmed: 29402290
Z Med Phys. 2019 Aug;29(3):249-261
pubmed: 30448049
Med Phys. 2014 Feb;41(2):021903
pubmed: 24506624
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):927-34
pubmed: 19095368
Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1553-61
pubmed: 17056197
Acta Oncol. 2015;54(9):1651-7
pubmed: 26198654
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):549-559
pubmed: 27084664
Radiother Oncol. 2012 Aug;104(2):249-56
pubmed: 22809588
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1045-56
pubmed: 18029110
Phys Med Biol. 2019 Nov 15;64(22):225004
pubmed: 31610527
Radiat Oncol. 2019 Jan 25;14(1):16
pubmed: 30683133
Int J Biomed Imaging. 2011;2011:891585
pubmed: 21197460
Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):919-26
pubmed: 19215826
Physiol Meas. 2011 Jan;32(1):19-34
pubmed: 21098909
IEEE Trans Med Imaging. 2009 Oct;28(10):1513-25
pubmed: 19211348
Med Phys. 2015 Mar;42(3):1354-66
pubmed: 25735290
Radiat Oncol. 2019 Oct 25;14(1):183
pubmed: 31653229
Med Phys. 2018 Nov;45(11):e1086-e1095
pubmed: 30421805
Int J Radiat Oncol Biol Phys. 2014 Jun 1;89(2):424-30
pubmed: 24726289
J Xray Sci Technol. 2015;23(1):11-23
pubmed: 25567403
Phys Med Biol. 2006 Jun 7;51(11):2939-52
pubmed: 16723776
Front Oncol. 2017 Sep 05;7:201
pubmed: 28929085
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):522-30
pubmed: 17418960
Med Phys. 2005 Apr;32(4):1176-86
pubmed: 15895601
Med Phys. 2008 Sep;35(9):3998-4011
pubmed: 18841851
Phys Med Biol. 2012 Mar 21;57(6):1517-25
pubmed: 22391045
Med Phys. 2014 Mar;41(3):031703
pubmed: 24593707
Med Phys. 2001 Feb;28(2):220-31
pubmed: 11243347
Radiother Oncol. 2014 Mar;110(3):529-37
pubmed: 24424385
Phys Med Biol. 2016 Sep 21;61(18):6856-6877
pubmed: 27588815
Phys Med Biol. 2012 Jul 7;57(13):4095-115
pubmed: 22678123
Med Phys. 2015 Aug;42(8):4783-95
pubmed: 26233206
J Oncol. 2011;2011:
pubmed: 20814539
Phys Med Biol. 2015 Jan 21;60(2):595-613
pubmed: 25548912
Med Phys. 2012 Dec;39(12):7603-18
pubmed: 23231308
Med Dosim. 2018 Summer;43(2):168-176
pubmed: 29650302
Int J Radiat Oncol Biol Phys. 2007 Jun 1;68(2):555-61
pubmed: 17398021
Med Phys. 2013 Oct;40(10):101912
pubmed: 24089914
Phys Med Biol. 2009 Aug 7;54(15):N329-46
pubmed: 19590116
Phys Med Biol. 2012 Jun 7;57(11):R99-117
pubmed: 22571913
Radiat Oncol. 2020 Mar 5;15(1):55
pubmed: 32138753
Med Phys. 2019 Mar;46(3):1140-1149
pubmed: 30609061
Phys Med Biol. 2013 Aug 7;58(15):R131-60
pubmed: 23863203
Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):e427-33
pubmed: 22672753
Radiat Oncol. 2018 Oct 11;13(1):199
pubmed: 30305125
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):582-9
pubmed: 18207034